Institutional HoldersBeta
Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.
Share classes (cover page of the 20-F filed 2026-03-09, as of 2025-12-31)
| Class | Listed | Shares outstanding | Held by 13F filers | % of class | Holders | CUSIP |
|---|---|---|---|---|---|---|
| Common stock | DRTS · NASDAQ | 88,009,737 | 7,967,442 | 9.1% | 74 | M0740A108 |
Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.
Top holders (74 of 74 · M0740A108)
change vs 2026-03-31Exited since 2026-03-31 (6 filers; largest 6 shown)
| MILLENNIUM MANAGEMENT LLC | −46,445 |
| RENAISSANCE TECHNOLOGIES LLC | −40,457 |
| GOLDMAN SACHS GROUP INC | −26,189 |
| JPMORGAN CHASE & CO | −5,020 |
| GROUP ONE TRADING LLC | −100 |
| Caitong International Asset Management Co., Ltd | −68 |
Large holders from 13D/13G (latest per reporting person, last 2 years)
Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.
| Reporting person | Form | Filed | Event | Shares | % of class |
|---|---|---|---|---|---|
| Uzi Sofer | SCHEDULE 13G | 2025-07-24 | 2022-12-31 | 13,702,361 | 15.8% |
| Oramed Ltd. | SCHEDULE 13D | 2025-05-01 | 2025-04-24 | 14,110,121 | 19.99% |
| Oramed Pharmaceuticals Inc. | SCHEDULE 13D | 2025-05-01 | 2025-04-24 | 14,110,121 | 19.99% |
Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.